Semaglutide or Tirzepatide, cannot be prescribed and should not be purchased by individuals with a BMI under 25, an eating disorder, diabetes, gallbladder disease, history of drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer or a family history of it, diabetic retinopathy, multiple endocrine neoplasia type 2, or those who are pregnant, breastfeeding, or planning to become pregnant
Optional prescription supplements Weight loss starting within 2-4 weeks We walk with you every step of the waynot just for quick results, but for lasting change
Actual product packaging and materials may contain more and/or different information than that shown on our website
Dublin audit While they are not currently approved by the US Food and Drug Administration for this indication, St Vincents Healthcare Group in Dublin uses GLP-1 RAs off label as adjunct therapies in select patients with type 1 diabetes to stabilise glucose control, reduce weight and reduce insulin TDD